PL327137A1 - Pain relieving agent - Google Patents

Pain relieving agent

Info

Publication number
PL327137A1
PL327137A1 PL96327137A PL32713796A PL327137A1 PL 327137 A1 PL327137 A1 PL 327137A1 PL 96327137 A PL96327137 A PL 96327137A PL 32713796 A PL32713796 A PL 32713796A PL 327137 A1 PL327137 A1 PL 327137A1
Authority
PL
Poland
Prior art keywords
pain relieving
relieving agent
agent
pain
relieving
Prior art date
Application number
PL96327137A
Inventor
Charles Howard Mitch
Harlan Edgar Shannon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL327137A1 publication Critical patent/PL327137A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL96327137A 1995-12-07 1996-12-05 Pain relieving agent PL327137A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US829995P 1995-12-07 1995-12-07
PCT/US1996/019309 WO1997020561A1 (en) 1995-12-07 1996-12-05 Composition for treating pain

Publications (1)

Publication Number Publication Date
PL327137A1 true PL327137A1 (en) 1998-11-23

Family

ID=21730869

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96327137A PL327137A1 (en) 1995-12-07 1996-12-05 Pain relieving agent

Country Status (13)

Country Link
EP (1) EP0871445A4 (en)
JP (1) JP2000501709A (en)
KR (1) KR19990071976A (en)
CN (1) CN1208349A (en)
AU (1) AU705031B2 (en)
CA (1) CA2238815A1 (en)
CZ (1) CZ174698A3 (en)
EA (1) EA199800533A1 (en)
IL (1) IL124419A0 (en)
NO (1) NO982562L (en)
NZ (1) NZ324988A (en)
PL (1) PL327137A1 (en)
WO (1) WO1997020561A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046227A1 (en) * 1997-04-11 1998-10-22 Eli Lilly And Company Composition for treating pain
ES2206244T3 (en) 1999-06-04 2004-05-16 Eli Lilly And Company 7-OX-2-AZABICICLO (2.2.1) HEPTANS AS SELECTIVE ANTAGONISTS OF THE MUSCARINIC RECEIVER.
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998450A (en) * 1958-05-19 1961-08-29 Warner Lambert Pharmaceutical Process of preparing nu-acetyl-p-amino phenol
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
US5260293A (en) * 1988-01-30 1993-11-09 Merck Sharp & Dohme Limited Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia
IL89351A0 (en) * 1988-03-14 1989-09-10 Lundbeck & Co As H 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
AU2121895A (en) * 1994-03-18 1995-10-09 Bayer Corporation Low dosage ketoprofen

Also Published As

Publication number Publication date
KR19990071976A (en) 1999-09-27
CN1208349A (en) 1999-02-17
EP0871445A1 (en) 1998-10-21
NO982562D0 (en) 1998-06-04
CZ174698A3 (en) 1998-10-14
CA2238815A1 (en) 1997-06-12
WO1997020561A1 (en) 1997-06-12
JP2000501709A (en) 2000-02-15
IL124419A0 (en) 1998-12-06
NO982562L (en) 1998-07-10
EA199800533A1 (en) 1999-02-25
EP0871445A4 (en) 2001-01-10
NZ324988A (en) 1999-08-30
AU1279197A (en) 1997-06-27
AU705031B2 (en) 1999-05-13

Similar Documents

Publication Publication Date Title
GB2298440B (en) Well treatment
GB9505491D0 (en) Therapeutic agents
GB9513118D0 (en) Therapeutic agents
GB9513121D0 (en) Therapeutic agents
GB9513117D0 (en) Therapeutic agents
GB9523244D0 (en) Therapeutic agents
GB9505492D0 (en) Therapeutic agents
GB9507291D0 (en) Therapeutic agents
GB9519033D0 (en) Treatment
GB9519563D0 (en) Therapeutic agents
GB9507348D0 (en) Therapeutic agents
GB9500580D0 (en) Therapeutic agents
GB9501865D0 (en) Therapeutic agents
GB9523250D0 (en) Therapeutic agents
PL327137A1 (en) Pain relieving agent
GB9513467D0 (en) Therapeutic agents
GB9523243D0 (en) Therapeutic agents
GB9521781D0 (en) Therapeutic agents
GB9522495D0 (en) Therapeutic agents
GB9510223D0 (en) Therapeutic agent
GB9519558D0 (en) Therapeutic agents
GB9523065D0 (en) Therapeutic agents
GB9520731D0 (en) Therapeutic agents
GB9522372D0 (en) Therapeutic agents
GB9523064D0 (en) Therapeutic agents